In the drug trial, researchers have shown that treatment with a type of sugar molecule called
cyclodextrin slows progression of the disease.
«Drug trial shows promise for deadly neurological disorder:
Cyclodextrin slows progression of Niemann - Pick type C.» ScienceDaily.
Not exact matches
In addition to demonstrating that disease
progression slowed with
cyclodextrin, Ory and his colleagues assessed biomarker measurements in the blood that showed evidence that the drug was removing cholesterol from the brain.